Endpoints News Feb 25, 2026 Polymer nanoparticle startup BreezeBio raises $60M for mRNA diabetes therapy
Endpoints News Feb 24, 2026 Novo Nordisk’s triple-G is competitive with Lilly in obesity, but likely to be second to market
Endpoints News Feb 24, 2026 Pfizer buys China rights to Sciwind’s approved GLP-1 drug in metabolic push